共 50 条
- [43] Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer [J]. JOURNAL OF UROLOGY, 2006, 176 (03): : 972 - 978
- [44] Bone mineral density in prostate cancer patients undergoing initial androgen deprivation therapy: Zoledronic acid vs. placebo [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 134 - 134
- [46] Evaluation of bone mass density on patients with prostate cancer prior to the start of androgen deprivation therapy [J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2009, 110 (09): : 559 - 562
- [47] Effect of muscle density in patients with metastatic prostate cancer administered androgen deprivation therapy [J]. ENDOCRINOLOGIA DIABETES Y NUTRICION, 2021, 68 (02): : 92 - 98
- [48] Patterns of Bone Mineral Density Testing in Men Receiving Androgen Deprivation for Prostate Cancer [J]. Journal of General Internal Medicine, 2013, 28 : 1440 - 1446
- [50] Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer [J]. Prostate Cancer and Prostatic Diseases, 2012, 15 : 308 - 312